BAROSTIM NEO Adverse Events: FDA MAUDE Data
CVRX, INC. · Carotid Sinus Nerve Stimulator (Barostim) · First cleared Jan 2024
Total Reports
117
Reports (30d)
3
Active Signals
0
Open Recalls
0
Evidence
Related research
Non-clinical and Pre-clinical Testing to Demonstrate Safety of the Barostim Neo Electrode for Activation of Carotid Baroreceptors in Chronic Human Implants.
Wilks SJ, et al. · Frontiers in neuroscience · 2017
Long-term efficacy and safety of first- and second-generation baroreflex activation devices in refractory hypertension: a single center retrospective analysis
Jessica Kaufeld, et al. · Blood Pressure · 2026
Baroreflex Amplification and Carotid Body Modulation for the Treatment of Resistant Hypertension
Eline H. Groenland, et al. · Current Hypertension Reports · 2020
Nonpharmacologic Treatment for Heart Failure
Boniface Malangu, et al. · Cardiology in Review · 2020
Implant-Mediated Therapy of Arterial Hypertension
Mortimer Gierthmuehlen, et al. · Current Hypertension Reports · 2020
Citations indexed from PubMed.
Keep exploring
Related devices in HF/Neuromod
Want automated safety signal detection?
Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more.
Get Early AccessUnderstanding this data